Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer
Sheila Fraser(Royal North Shore Hospital), Stan B. Sidhu(Royal North Shore Hospital), Nisar Zaidi(The University of Sydney), Anthony Glover(The University of Sydney), Mark Sywak(Royal North Shore Hospital), Leigh Delbridge(The University of Sydney), Olov Norlén(Uppsala University), Schelto Kruijff(University Medical Center Groningen)
Cited by 29
Related Papers
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer
|Surgery|2006|379
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
|Surgery|2011|266
Long‐Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
|World Journal of Surgery|2011|256
Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
|PLoS ONE|2012|184
Activating mutations in CTNNB1 in aldosterone producing adenomas
|Scientific Reports|2016|172